Phaseline

Targets › LTF

LTF (Lactotransferrin): drug programs, companies and trials

2 programs from 2 companies in 4 trials: 3 Phase 3, 1 Phase 2; Hematology, Gastroenterology; next expected readout Dec 2026.

Transferrins are iron binding transport proteins which can bind two Fe(3+) ions in association with the binding of an anion, usually bicarbonate..; FUNCTION: [Lactotransferrin]: Major iron-binding and multifunctional protein found in exocrine fluids such as breast milk and mucosal secretions. Has antimicrobial activity, which depends on the extracellular cation concentration. (UniProt, P02788)

Open in Phaseline: the race on LTF, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
University of WashingtonLactoferrin
Combination of iron-binding glycoprotein and antimicrobial enzyme for enhanced intestinal
LTF, LYZPhase 3DiarrheaDec 2026
Beni-Suef UniversityLactoferrin
Iron-binding protein; enhances iron absorption and utilization
LTFPhase 2Iron Deficiency Anemia (IDA)Dec 2026

Conditions

Diarrhea (3) Iron Deficiency Anemia (IDA) (1)

Modalities

small molecule (1)

Companies

Beni-Suef University (1) University of Washington (1)

Related targets

LYZ (1)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.